Abstract: The present disclosure relates to methods for treating at least one source of proteins, treated protein material obtainable by said method of treatment, and food compositions for animals, preferably for pets, including said treated protein material.

Abstract: The present disclosure relates to compositions comprising a range of ingredients suitable for use in adjusting and/or treating a companion animal such as a canid (e.g. a dog) or a feline (e.g. a cat) and their microbiomes, monitoring tools, and diagnostic methods for determining the health of a companion animal and their microbiome.

Abstract: The presently disclosed subject matter provides methods of treating animal proteins and pet food products including the same. Methods include treating animal proteins with one or more base compounds to increase the pH thereof to provide for increased preservation and the reduction of spoilage of the animal protein.

Abstract: An apparatus is provided for use with a tissue anchor and an anchor driver. The apparatus includes a housing, shaped to define a channel. The channel includes (i) an anchor-storage zone, and (ii) a proximal opening configured to provide access for the anchor driver to the anchor-storage zone. The channel is configured to enable sliding of the tissue anchor therewithin to be stored in the anchor-storage zone. The apparatus also includes a retaining member, shaped to define a cradle for cradling and holding the tissue anchor in the anchor-storage zone. The retaining member includes a pillar pivotable with respect to the cradle, and configured to support the tissue anchor at the cradle. Other embodiments are also described.

Abstract: Steerable delivery devices use one or more pull wires. Described herein are devices and methods for securing a pull wire to an adjustment mechanism of such delivery devices. The disclosed devices facilitate securing the pull wire by using a wrapping set screw that forms a lumen for the pull wire and one or more notches in the side of the wrapping set screw at its proximal end. The notches allow the pull wire to be pulled through a notch so that when the wrapping set screw is driven into a threaded lumen the pull wire lies along the roots of the screw. The pull wire is secured in place due at least in part to friction and/or to being pressed between the screw and the threaded lumen of a wrap housing where the wrap housing can be part of the adjustment mechanism of the delivery device.

Abstract: An electronic system (and corresponding method) for creating and managing media content involves at least one content management system (CMS) and a service. The CMS is configured to interact with at least one first-type user in order to create and manage media content for publication. The service is configured to interact with a plurality of second-type users in order to submit media content items that are associated with media content managed by the CMS and to store such media content items. Both the CMS and the service include corresponding interfaces that allow for exchange of electronic messages therebetween via network communications over the Internet, wherein the electronic messages conform to a predefined protocol.

Abstract: An alternative illumination source for traditional optical microscopes is provided. This super-resolution illumination source permits to use a traditional optical microscope for the direct observation of objects smaller than 100 nanometers such as subcellular structures in microorganisms, carbon nanotubes and other nanosize objects, and even nanostructures fabricated on top of a silicon wafer. This invention relies on the integration of two functional elements: a microscope, and the super-resolution illumination source. The super-resolution illumination source is formed by an array of light emitting diodes (LEDs) uniformly distributed in a hemisphere. The object under observation is illuminated by the light emitted in all directions by the array of LEDs. Real, wide-field images of the sample with nano-resolution are direct and analogically formed by the microscope's lenses, without the need of sample tagging, intensive computation or scanning.

Abstract: Compositions and methods for treating ocular diseases and disorders are provided. The composition can contain at least one lantibiotic, which can be administered topically by injection, systemically, or by other appropriate means. The methods provided include the administration of a therapeutically effective amount of a formulation containing at least one lantibiotic to the appropriate section of the eye.

Abstract: Compositions useful for treating membrane-associated diseases, conditions, and disorders, including inflammatory diseases, dry mouth, primary ciliary dyskinesia and platelet aggregating disorders, are disclosed which comprise at least one lantibiotic compound. Also disclosed are pharmaceutical compositions and methods of treatment for membrane-associated diseases such as inflammation and dermal irritation, as well as use of such compositions in the treatment of membrane-associated diseases, wherein the pharmaceutical compositions contain at least one lantibiotic.

Abstract: Nucleic acids encoding preduramycin and produramycin are described, along with recombinant nucleic acids host cells containing the same and methods of use thereof, such as for the manufacture of the lantibiotic duramycin.

Abstract: Compositions useful for treating membrane-associated diseases, conditions, and disorders, including inflammatory diseases, dry mouth, primary ciliary dyskinesia and platelet aggregating disorders, are disclosed which comprise at least one lantibiotic compound. Also disclosed are pharmaceutical compositions and methods of treatment for membrane-associated diseases such as inflammation and dermal irritation, as well as use of such compositions in the treatment of membrane-associated diseases, wherein the pharmaceutical compositions contain at least one lantibiotic.

Abstract: Nucleic acids encoding preduramycin and produramycin are described, along with recombinant nucleic acids and host cells containing the same and methods of use thereof, such as for the manufacture of the lantibiotic duramycin.

Abstract: Nucleic acids encoding preduramycin and produramycin are described, along with recombinant nucleic acids and host cells containing the same and methods of use thereof, such as for the manufacture of the lantibiotic duramycin.

Abstract: The use of transition metal complexes in the treatment of septic shock, in particular the hypotension associated therewith and pharmaceutical formulations comprising such complexes are disclosed. The use of such transition metal complexes in the treatment of other conditions caused by pathological NO production are also disclosed.

Abstract: The treatment of dry eye disease with lantibiotics such as duramycin is described, along with pharmaceutical formulations useful for carrying out such treatments.

Abstract: Compositions useful for treating membrane-associated diseases, conditions, and disorders, including inflammatory diseases, dry mouth, primary ciliary dyskinesia and platelet aggregating disorders, are disclosed which comprise at least one lantibiotic compound. Also disclosed are pharmaceutical compositions and methods of treatment for membrane-associated diseases such as inflammation and dermal irritation, as well as use of such compositions in the treatment of membrane-associated diseases, wherein the pharmaceutical compositions contain at least one lantibiotic.

Abstract: Compositions and methods for treating ocular diseases and disorders are provided. The composition can contain at least one lantibiotic, which can be administered topically by injection, systemically, or by other appropriate means. The methods provided include the administration of a therapeutically effective amount of a formulation containing at least one lantibiotic to the appropriate section of the eye.

Abstract: The use of transition metal complexes in the treatment of septic shock, in particular the hypotension associated therewith and pharmaceutical formulations comprising such complexes are disclosed. The use of such transition metal complexes in the treatment of other conditions caused by pathological NO production are also disclosed.

Abstract: The use of transition metal complexes in the treatment of septic shock, in particular the hypotension associated therewith and pharmaceutical formulation comprising such complexes are disclosed. The use of such transition metal complexes in the treatment of other conditions caused by pathological NO production are also disclosed.